Influence of low high-density lipoprotein cholesterol on arterial stiffening and left ventricular diastolic

Dong-Mei Miao1, Ping Ye, Wen-Kai Xiao

  • 1Department 2 of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, China.

Insights

Low high-density lipoprotein (HDL) cholesterol is linked to arterial stiffening and impaired heart function in essential hypertension. This study found low HDL cholesterol independently predicts these cardiovascular issues in patients.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Hypertension Research

Background:

  • Essential hypertension is a major risk factor for cardiovascular disease.
  • Arterial stiffening and left ventricular (LV) diastolic dysfunction are common complications.
  • The role of lipid profiles, particularly high-density lipoprotein (HDL) cholesterol, in these complications requires further elucidation.

Purpose of the Study:

  • To investigate the association between high-density lipoprotein (HDL) cholesterol levels and arterial stiffening.
  • To examine the relationship between HDL cholesterol and left ventricular (LV) diastolic function in patients with essential hypertension.
  • To determine if low HDL cholesterol is an independent predictor of arterial stiffness and LV diastolic dysfunction.

Main Methods:

  • Cross-sectional study involving 217 patients with essential hypertension.
  • Evaluation of carotid arterial stiffness parameter and LV diastolic function index (E/Em).
  • Correlation and multiple regression analyses to assess the impact of dyslipidemia, especially HDL cholesterol, on arterial stiffness and LV diastolic function.

Main Results:

  • Arterial stiffness parameter positively correlated with E/Em (LV diastolic function index).
  • HDL cholesterol showed an inverse association with both arterial stiffness parameter and E/Em.
  • Low HDL cholesterol emerged as an independent predictor for both increased arterial stiffness and LV diastolic dysfunction.

Conclusions:

  • Enhanced arterial stiffness is associated with impaired LV diastolic function in essential hypertension.
  • Low levels of HDL cholesterol may contribute to the progression of arterial stiffness and LV diastolic dysfunction.
  • Maintaining adequate HDL cholesterol levels could be crucial for cardiovascular health in hypertensive patients.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...